Skip to main content
. Author manuscript; available in PMC: 2016 Mar 7.
Published in final edited form as: J Proteomics Bioinform. 2015;8(2):031–038. doi: 10.4172/jpb.1000350

Figure 1.

Figure 1

Methodology for serum labelling procedure from kidney transplant patient differing in graft survival vs. normal controls. Proteins from kidney transplant serum at different stages of the disease (sample) vs. normal serum (control) were labeled with Cy3 or Cy5 dyes, respectively, and analyzed on an antibody microarray platform.